Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 82
Filter
1.
Indian J Psychiatry ; 65(5): 558-564, 2023 May.
Article in English | MEDLINE | ID: covidwho-20236282

ABSTRACT

Background: While telepsychiatry became a prominent and widely used service in the COVID-19 pandemic-related lockdown, data regarding the patient's experience of telepsychiatry consultations is lacking. Materials and Methods: In this study, we attempted to understand the experience and level of satisfaction of 129 patients receiving psychiatry consultations over video consultations from April 2021 to December 2021. We also tried to understand the factors that might be associated with the satisfaction of the patients. Results: About three-fourths (77.5%) of the respondents were very satisfied with the quality of care provided and the overall experience of the consultation. The majority (92.2%) of the respondents reported that they would "definitely" recommend the telepsychiatry service to a friend or relative in need of a psychiatric consultation. The majority of the patients expressed high levels of satisfaction with the amount of time spent, the amount of freedom in expressing themselves, the amount of freedom in choosing the treatment option, the prescription provided, and the number of medications prescribed. The clarity of voice and the quality of connectivity throughout the consultation were found to be associated with the level of satisfaction. Conclusions: The present study suggests that overall satisfaction with teleconsultations was high among patients and/or caregivers for telepsychiatry consultations.

2.
J Obstet Gynaecol India ; : 1, 2023 Apr 29.
Article in English | MEDLINE | ID: covidwho-2323914

ABSTRACT

[This corrects the article DOI: 10.1007/s13224-022-01737-5.].

3.
J Clin Psychopharmacol ; 43(3): 239-245, 2023.
Article in English | MEDLINE | ID: covidwho-2313996

ABSTRACT

PURPOSE/BACKGROUND: A recent article in this journal presented a US perspective regarding the modernization of clozapine prescription and proposed an escape from the long shadow cast by agranulocytosis. METHODS: Here, an international group of collaborators discusses a point of view complementary to the US view by focusing on worldwide outcomes of clozapine usage that may be uneven in terms of frequency of clozapine adverse drug reactions. FINDINGS/RESULTS: Studies from the Scandinavian national registries (Finland and Denmark) did not find increased mortality in clozapine patients or any clear evidence of the alleged toxicity of clozapine. Data on clozapine-associated fatal outcomes were obtained from 2 recently published pharmacovigilance studies and from the UK pharmacovigilance database. A pharmacovigilance study focused on physician reports to assess worldwide lethality of drugs from 2010 to 2019 found 968 clozapine-associated fatal outcomes in the United Kingdom. Moreover, the United Kingdom accounted for 55% (968 of 1761) of worldwide and 90% (968 of 1073) of European fatal clozapine-associated outcomes. In a pharmacovigilance study from the UK database (from 2008 to 2017), clozapine was associated with 383 fatal outcomes/year including all reports from physicians and nonphysicians. From 2018 to 2021, UK clozapine-associated fatal outcomes increased to 440/year. IMPLICATIONS/CONCLUSIONS: The interpretation of fatal outcomes in each country using pharmacovigilance databases is limited and only allows gross comparisons; even with those limitations, the UK data seem concerning. Pneumonia and myocarditis may be more important than agranulocytosis in explaining the uneven distribution of fatal outcomes in clozapine patients across countries.


Subject(s)
Agranulocytosis , Antipsychotic Agents , Clozapine , Humans , Clozapine/adverse effects , Antipsychotic Agents/adverse effects , Pharmacovigilance , Agranulocytosis/chemically induced , United Kingdom
4.
J Obstet Gynaecol India ; : 1, 2023 Apr 29.
Article in English | MEDLINE | ID: covidwho-2315800

ABSTRACT

[This corrects the article DOI: 10.1007/s13224-022-01737-5.].

5.
Nursing and Midwifery Research Journal ; 18(2):97-109, 2022.
Article in English | ProQuest Central | ID: covidwho-2297421

ABSTRACT

Introduction: The literature related to quarantined nurses' lived experiences working in nondesignated COVID settings is scarce. This study aimed to explore the lived experiences of quarantined nurses after accidental exposure in nondesignated COVID areas in a tertiary care hospital. Material and Methods: It was a qualitative phenomenological study. Snowball sampling technique was used to interview 11 nurses. The in-depth interviews were conducted telephonically using a prevalidated interview guide during October 2020 to February 2021. The interviews were audiotaped, transcribed, and translated to English. Thematic analysis was done using Colaizzi's phenomenological method. The findings depicting similar codes were grouped into subthemes and themes. The findings are presented thematically with corresponding participant quotes. Results: Out of 11, six (55%) participants were quarantined in home and five (45%) in the institutional facilities. The major themes that emerged were: "psychological reactions," "quarantine: the positive aspect," and "support system" among the home quarantined nurses. The major themes in the institutional facility quarantined nurses were: "psychological reactions," "poor quality of institutional quarantine facility," "quarantine: the positive aspect," "support system," and "quarantine: a learning experience." The nurses experienced various negative emotions during quarantine. Conclusion: To safeguard the physical and mental health of nurses, comprehensive support should be provided by the authorities in terms of availability of basic amenities and quality services during quarantine. Regular training and constant motivation are needed to promote their mental preparedness for crisis management.

6.
Indian J Psychiatry ; 65(3): 385-386, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2268100
7.
Psychiatr Danub ; 34(Suppl 10): 190-197, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2235141

ABSTRACT

BACKGROUND: The COVID-19 pandemic has led to widespread controversies related to the transmission, treatment, prevention, and management of COVID-19 infection. Medical students have been involved in patient care across the globe and many a times the general public looks forward towards the medical professionals to get proper information about various issues related to COVID-19. We aimed to evaluate the knowledge and misconceptions held by the medical students on various aspects of COVID-19 infection. SUBJECTS AND METHODS: An online cross-sectional survey was conducted through the Survey Monkey® platform using the Whatsapp®, among the medical undergraduate students of a tertiary care Institute of Eastern India. RESULTS: 236 medical students (of different years of medical training/MBBS) participated in the survey and the response rate to the survey was 47.2%. The mean age of the participants was 20.91 (SD-1.86) years, and about three-fifths were males (58.5%). One-third students were either in their first year of MBBS (31.8%) or the final year (35.16%) of MBBS. Incorrect beliefs related to various preventive aspects, risk of increasing chance of getting infection and modes of spread of infection were present in a significant proportion of students, with a wide variation for specific issues. When the number of participants with at least one incorrect related to any of the aspects of COVID-19 infection was evaluated, it ranged from 59% to 85% in different domains. CONCLUSIONS: This survey highlights the widespread prevalence of misconceptions about various aspects of COVID-19 among medical students, which needs to be addressed by proper education and awareness.


Subject(s)
COVID-19 , Students, Medical , Male , Humans , Female , COVID-19/epidemiology , Cross-Sectional Studies , Pandemics , Health Knowledge, Attitudes, Practice
8.
J Midlife Health ; 13(3): 233-240, 2022.
Article in English | MEDLINE | ID: covidwho-2231848

ABSTRACT

Background: Peri- and post-menopausal women are vulnerable to suffer from mental health problems including depression, anxiety, and stress, which might have increased during the COVID-19 pandemic. Objective: To estimate the prevalence of depression and associated factors among peri- and post-menopausal women during the COVID-19 pandemic in Chandigarh. Materials and Methods: A community-based cross-sectional study was conducted among 200 urban peri- and post-menopausal women of age 40-60 years in Chandigarh, from May to June 2021. Patient Health Questionnaire-9, Generalized Anxiety Disorder 7, and EuroQol-5D validated tools were used to screen depression, anxiety, and quality of life (QOL). Fear of COVID-19 scale was developed as part of this study was used to assess the fear related to COVID-19 infection. Data analysis was done using the Statistical Package for the Social Sciences (SPSS) software version 26.0. Binary multivariate logistic regression model was used to identify the predictors. Results: The prevalence of depression was 39% and anxiety 29.5% among peri-and post-menopausal women. The fear of COVID-19 infection (adjusted odds ratio [aOR] 8.43, confidence interval [CI]: 1.99-35.64; aOR 10.54, CI: 2.76-40.24) and sleeplessness (aOR 13.29, CI: 3.22-54.82) were the significant (P < 0.005) predictors of depression and anxiety, respectively. Fearful peri- and post-menopausal women (aOR 5.94, CI: 2.68-13.13) and widow status (aOR 7.08, CI: 1.10-45.28) were the significant (P < 0.005) predictors of poor QOL. Conclusions: The prevalence of depression was high among peri- and post-menopausal women during the COVID-19 pandemic. Fear of getting COVID-19 infection was significantly associated with depression, anxiety, and poor QOL.

9.
Vaccine ; 41(11): 1791-1798, 2023 03 10.
Article in English | MEDLINE | ID: covidwho-2236865

ABSTRACT

IMPORTANCE: Solid cancer patients following SARS-CoV-2 vaccination are likely to have a lower seroconversion rate than healthy adults. Seroconversion between those with and without cancer is likely to vary moderately or to be restricted to specific subgroups. Therefore, we sought to conduct a systematic review and meta-analysis to identify risk factors for diminished humoral immune responses in solid cancer patients. METHODS: MEDLINE, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov were used to search literature through May 1, 2022. Prospective or retrospective studies comparing responders with non-responders against SARS-CoV-2 spike (S) protein receptor-binding domain (RBD) following COVID-19 vaccination were included. Pooled Odds Ratios (pORs) with 95% CIs for binary variables and differences in means (with SDs) for continuous variables were calculated to determine the pooled effect estimates of risk factors for poor antibody response. RESULTS: Fifteen studies enrolling 3593 patients were included in the analysis. Seroconversion was seen in 84% of the pooled study population. Male gender, age >65 years, and recent chemotherapy were all factors in a poor immune response. Patients under follow-up, those who received immunotherapy or targeted therapy, were more likely to be seropositive. Cancer subtypes, vaccine types, and timing of antibody testing from the 2nd dose of vaccine did not correlate with seroconversion. CONCLUSION: Cytotoxic therapy for solid cancer may portend poor immune response following 2 doses of COVID-19 vaccines suggesting a need for booster doses in these patients. Immunotherapy and targeted therapy are likely to be associated with seropositive status, and thus can be considered as an alternative to cytotoxic agents in cases where both therapies are equally efficacious.


Subject(s)
COVID-19 , Neoplasms , Adult , Humans , Male , Aged , COVID-19 Vaccines/therapeutic use , Immunity, Humoral , Prospective Studies , Retrospective Studies , COVID-19/prevention & control , SARS-CoV-2 , Neoplasms/therapy , Antibodies, Viral , Vaccination
10.
J Obstet Gynaecol India ; 73(3): 279-281, 2023 Jun.
Article in English | MEDLINE | ID: covidwho-2175214

ABSTRACT

Postpartum collapse is a life-threatening condition caused by obstetrical and non-obstetrical events. In this case report, we discuss a case of postpartum collapse in COVID-19-positive woman who required intensive care and mechanical ventilation for two days. After confusing collision of many provisional diagnoses soldiering for three days, she was ultimately diagnosed with malignant catatonia. Targeted therapy with lorazepam challenge resulted in drastic improvement, and she was discharged with her baby in healthy condition.

12.
Schizophr Bull Open ; 3(1): sgac043, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-2107583

ABSTRACT

India with a population of 1.3 billion has a unique health care system in its different states. Mental health care varies widely across the country and this became even more apparent after the COVID-19 pandemic set in. This paper examines the various strategies in response to COVID-19 adopted by the Government of India, the health departments of the individual states, and other private players such as on-government organizations and the civil society. The cessation of many services including outpatient and inpatient care and the scarcity of medicines were serious impacts of COVID-19. The prolonged lockdown in many parts of the country impeded access to mental health care services since public transport was unavailable. This led to many relapses in persons with serious mental disorders. The emergence of new cases of psychosis and an increase in suicides were also seen. Tele consultations came to the fore and many helplines were started offering counseling and guidance regarding the availability of mental health care facilities. While these helped the urban dwellers, those in remote and rural areas were unable to use these services effectively. Many mental health wards were used for COVID-19 patients and mental health professionals were deployed for COVID-19 related duty. The severely mentally ill, the homeless mentally ill, and the elderly were especially vulnerable. Based on our experience with COVID-19, we urge a strong call for action, in terms of strengthening the primary care facilities and increasing the manpower resources to deliver mental health care.

13.
Indian J Psychiatry ; 64(5): 473-483, 2022.
Article in English | MEDLINE | ID: covidwho-2100028

ABSTRACT

Background: Many studies across the globe have evaluated the adverse mental health consequences of COVID-19 in patients who suffered from COVID-19 infection. However, a comparative study of persons who suffered from COVID-19 infection and those who witnessed the COVID-19 infection in their close relatives is lacking. Aims and Objectives: This study aims to compare the psychiatric morbidity in persons who suffered from COVID-19 infections, and those who witnessed the illness in one of their close relatives. Methods: In this cross-sectional online survey, 2,964 adult participants completed the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7) Scale, Fear of COVID-19 Scale (FCS-19), Brief Resilient Coping Scale (BRCS), The Brief Resilience Scale (BRS) and a self-designed questionnaire to evaluate other neuropsychiatric complications. Results: Compared to the close relatives who had witnessed COVID-19 infection, participants who developed COVID-19 infection had a significantly higher prevalence of depression (34.6%), anxiety disorder (32.3%), and fear of COVID-19 infection (18.8%), which was significantly higher than that noted in close relatives. However, BRS coping score was not significantly different between the two groups. Overall, about one-third of the participants who developed COVID-19 infection had depression and one-third had anxiety disorders. One-fifth of the participants reported high fear, post-traumatic symptoms, and obsessive-compulsive symptoms, whereas one-sixth reported other neuropsychiatric manifestations. Conclusion: Patients who suffered from COVID-19 have a higher prevalence of depression, anxiety, and fear as compared to those to witnessed COVID-19 in relatives.

14.
Asian J Psychiatr ; 75: 103207, 2022 09.
Article in English | MEDLINE | ID: covidwho-2014783
15.
Indian journal of psychiatry ; 64(Suppl 3):S512-S512, 2022.
Article in English | EuropePMC | ID: covidwho-1871887

ABSTRACT

Background: Few studies across the globe have evaluated the adverse mental health consequences of COVID-19, in patients who suffered from COVID-19 infection. However, a comparative study of persons who suffered from COVID-19 and those who witnessed the COVID-19 infection in their 1 st degree relative/s is lacking. Aims & Objectives: This study aims to compare the psychiatric morbidity in persons who suffered from COVID-19 infections, and those who witnessed the illness in one of their first degree relative/s. Methods: In this cross-sectional online survey, 2964 adult participants completed the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), Fear of COVID-19 Scale (FCS-19), Brief Resilient Coping Scale (BRCS), The Brief Resilience Scale (BRS) and a self-designed questionnaire to evaluate Neuropsychiatric issues. Results- Mean PHQ-9, GAD-7 and FCS-19 were significantly higher in those who themselves suffered from COVID-19 as compared to those who witnessed the infection in their 1 st degree relative (7.41 ± 7.09 vs 6.56 ± 6.15;p<0.0001;5.58 ± 6.59 vs 5.10 ± 5.97;p=0.001;11.32±6.45 vs 10.48±6.12;p=0.001 respectively). However, BRS coping score was not significantly different between both the groups. Overall, about 1/3 rd of the participants who developed COVID-19 infection had depression and one-third had anxiety disorders. One-fifth of the participants reported high fear, PTSD and OCD symptoms, while 1/6 th reported other neuropsychiatric manifestations. Conclusion: Patients who suffered from COVID-19 had higher prevalence of PHQ-9, GAD-7 and FCS-19 as compared to those to witnessed COVID-19 in relatives but with similar BRCS.

16.
Indian journal of psychiatry ; 64(Suppl 3):S556-S556, 2022.
Article in English | EuropePMC | ID: covidwho-1871596

ABSTRACT

Background: The COVID-19 pandemic has led to expansion of telepsychiatry services and formulation of telemedicine guidelines. However, the telemedicine guidelines are not very clear about psychiatric emergencies, such as suicidal behaviour, resulting in psychiatrists facing dilemma about handling such situations. Aim: To evaluate the prevalence of suicidal behaviour in new patients presenting to the Telepsychiatry services in a Tertiary Care centre and how patients with suicidal behaviour were handled during the initial consultation. Methods: All new adult patients (aged >18 years) registered with telepsychiatry services during 19th July to 20th of Sept 2021 were assessed for suicidal behaviour, in the form of death wishes, suicidal ideations, plans, attempts (lifetime/recent) and non-suicidal self-injurious behaviour (NSSI) (lifetime/recent). Results: The study included 1065 adult patients (aged≥18 years). In terms of suicidal behaviour, in the last few weeks prior to assessment 14.4% ofthe patients had death wishes, 2.4% had thoughts of killing themselves, 0.9% had attempted suicide in the lifetime and 0.6% in thelast few weeks, 1.1% had active suicidal ideations at the time of assessment, 0.6% had active suicidal plan, 1.3% had history of non-suicidal self-injurious behaviour (NSSI) in the lifetime and0.5% had NSSI behaviour in the last few weeks. Based on the suicidality, 1% of thepatients were asked to report to the emergency immediately, 1.4% were given an appointment within 72 hours for follow-up and 3.6% were explained high risk management. Conclusions: Suicidal behaviour, especially active suicidal ideations and suicidal plan is not very prevalent in patients seeking telepsychiatry consultation.

17.
Indian journal of psychiatry ; 64(Suppl 3):S528-S528, 2022.
Article in English | EuropePMC | ID: covidwho-1871437

ABSTRACT

Background: During the Covid-19 pandemic, telepsychiatry has become normalised in multiple institutes across India as the primary method of care delivery. However, not much evidence is available regarding the experience of a tele-psychiatry consultation for both the care-providing clinician as well as the recipient. Objective: This study aims to assess the experience and satisfaction of the clinician and the patients/their caregiver during a telepsychiatry consultation. Methods: Clinicians scored their experience of providing the consultation to patients over a call(video/audio) in a detailed Google form based questionnaire on a 6 point Likert scale, ranging from very dissatisfied to very satisfied. Patient’s sociodemographic details were collected in a standard manner. Patients were sent a modified version of the Google form questionnaire on their registered mobile number to report their degree of satisfaction, after the call ended. Results: 371 consecutive teleconsultations between April to June 2021 were assessed by 3 clinicians, of which 132 patients/caregivers responded back. The patients had a mean age of 43.5 years, were mostly male, married, educated beyond matric, employed and belonged to urban nuclear families. The average distance of their location from the hospital was 178 km and more than 80% of the patients were accompanied by their relatives in the teleconsultation. 53.6% of the consultations did not face any technological problems, while 24% had connectivity issues from the patient side. Overall, ~66.8% clinicians and 62% of the patients reported being satisfied to a large extent. 66% of the clinicians felt teleconsultation experience was same as an in-person consultation. Conclusions: Teleconsultation in psychiatric patients might not be as difficult as intuitively thought and needs to be explored further as an opportunity to reach out to a larger population, beyond the urban educated sociodemographic group who are the primary beneficiaries in the current scenario.

18.
Infect Genet Evol ; 102: 105299, 2022 08.
Article in English | MEDLINE | ID: covidwho-1821418

ABSTRACT

Pneumonia, an acute respiratory tract infection, is one of the major causes of mortality worldwide. Depending on the site of acquisition, pneumonia can be community acquired pneumonia (CAP) or nosocomial pneumonia (NP). The risk of pneumonia, is partially driven by host genetics. CYP1A1 is a widely studied pulmonary CYP family gene primarily expressed in peripheral airway epithelium. The CYP1A1 genetic variants, included in this study, alter the gene activity and are known to contribute in lung inflammation, which may cause pneumonia pathogenesis. In this study, we performed a meta-analysis to establish the possible contribution of CYP1A1 gene, and its three variants (rs2606345, rs1048943 and rs4646903) towards the genetic etiology of pneumonia risk. Using PRISMA guidelines, we systematically reviewed and meta-analysed case-control studies, evaluating risk of pneumonia in patients carrying the risk alleles of CYP1A1 variants. Heterogeneity across the studies was evaluated using I2 statistics. Based on heterogeneity, a random-effect (using maximum likelihood) or fixed-effect (using inverse variance) model was applied to estimate the effect size. Pooled odds ratio (OR) was calculated to estimate the overall effect of the risk allele association with pneumonia susceptibility. Egger's regression test and funnel plot were used to assess publication bias. Subgroup analysis was performed based on pneumonia type (CAP and NP), population, as well as age group. A total of ten articles were identified as eligible studies, which included 3049 cases and 2249 healthy controls. The meta-analysis findings revealed CYP1A1 variants, rs2606345 [T vs G; OR = 1.12 (0.75-1.50); p = 0.02; I2 = 84.89%], and rs1048943 [G vs T; OR = 1.19 (0.76-1.61); p = 0.02; I2 = 0.00%] as risk markers whereas rs4646903 showed no statistical significance for susceptibility to pneumonia. On subgroup analysis, both the genetic variants showed significant association with CAP but not with NP. We additionally performed a spatial analysis to identify the key factors possibly explaining the variability across countries in the prevalence of the coronavirus disease 2019 (COVID-19), a viral pneumonia. We observed a significant association between the risk allele of rs2606345 and rs1048943, with a higher COVID-19 prevalence worldwide, providing us important links in understanding the variability in COVID-19 prevalence.


Subject(s)
COVID-19 , Community-Acquired Infections , Pneumonia , COVID-19/genetics , Cues , Cytochrome P-450 CYP1A1/genetics , Genetic Predisposition to Disease , Human Genetics , Humans , Pneumonia/genetics , Polymorphism, Single Nucleotide , Risk Factors
19.
Asian J Psychiatr ; 74: 103152, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1821103

ABSTRACT

BACKGROUND: The COVID-19 pandemic has led to expansion of telepsychiatry services and formulation of telemedicine guidelines. However, the telemedicine guidelines are not very clear about psychiatric emergencies, such as suicidal behaviour, resulting in psychiatrists facing dilemma about handling such situations. AIM: To evaluate the prevalence of suicidal behaviour in new patients presenting to the Telepsychiatry services in a Tertiary Care centre. METHODS: 1065 new adult patients (aged > 18 years) registered with telepsychiatry services were assessed for suicidal behaviour, in the form of death wishes, suicidal ideations, plans, attempts (lifetime/recent) and non-suicidal self-injurious behaviour (NSSI) (lifetime/recent). RESULTS: In terms of suicidal behaviour, in the last few weeks prior to assessment 14.4% of the patients had death wishes, 2.4% had thoughts of killing themselves, 0.9% had attempted suicide in the lifetime and 0.6% in the last few weeks, 1.1% had active suicidal ideations at the time of assessment, 0.6% had active suicidal plan, 1.3% had history of NSSI in the lifetime and 0.5% had NSSI behaviour in the last few weeks. Based on the current suicidal behaviour, 1.3% of the patients were asked to report to the emergency immediately, 0.5% were given an appointment within 72 h for follow-up, and 14.4% were explained high risk management. CONCLUSIONS: Overall prevalence of suicidal behavior is relatively low in new patients seeking psychiatric help through telepsychiatry services.


Subject(s)
Mental Disorders , Mental Health Services , Suicidal Ideation , Telemedicine , Adult , COVID-19/epidemiology , Humans , Mental Disorders/therapy , Mental Health Services/organization & administration , Pandemics , Telemedicine/organization & administration , Tertiary Care Centers
20.
Indian J Psychiatry ; 64(Suppl 2): S499-S508, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1776460
SELECTION OF CITATIONS
SEARCH DETAIL